Sunday, June 15
19.30-21.30  Red Hall

  First, lower the blood pressure.....AIIRAs: the ideal therapeutic approach?
  Sponsored by Bristol-Myers Squibb/ Sanofi Synthelabo
   
Chairmen:
N. Hollenberg (Boston, MA, USA)
L.M. Ruilope (Madrid, Spain)

> Optimising hypertension therapy with AIIRAs
B. Waeber (Lausanne, Switzerland)

> Evidence based benefits of AIIRAs in hypertensive diabetics
J. Lewis (Nashville, TN, USA)

> Emerging data from the Irbesartan Diabetic Nephropathy Trial (IDNT)
E.J. Lewis (Chicago, IL, USA)

> Minimising cardiovascular sequellae of hypertension
P. Carson (Washington, DC, USA)
  For information contact:
Mrs. Eleonora Pasqualini
AISC & MGR  - AIM Group
Via A. Ristori, 38 - 00197 Rome (Italy)
Tel. +39-0680968304 - Fax. +39.0680968229
E-Mail: e.pasqualini@aisc.it

Back to the Main Programme Index